ArticleScientific reports2024

Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity.

Tokiwa Motonari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.